Results 21 to 30 of about 38,780 (255)

Juvenile Human T Lymphotropic Virus Type 1–Associated Myelopathy [PDF]

open access: yesClinical Infectious Diseases, 2002
We report the cases of 5 adolescents with human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis, acquired in all but 1 case from the mother. The first symptom in all patients was difficulty in running, which was present for many years before the final diagnosis was made.
Alexandra P Q C, Araújo   +4 more
openaire   +2 more sources

Organizing pneumonia in a carrier of human T-cell lymphotropic virus type-1

open access: yesAnnals of Thoracic Medicine, 2020
Human T-cell lymphotropic virus type-1 (HTLV-1)-associated bronchioloalveolar disorders (HABAs) are pulmonary disorders with various interstitial lung disease patterns that often occur in HTLV-1 carriers.
Masahiro Yamasaki   +3 more
doaj   +1 more source

Sexually Transmitted Diseases: from HPV to HTLV - clinical profile and associated factors [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2015
: The Brazilian Ministry of Health recommends the performance of serological tests in patients with clinical signs of Sexually Transmitted Diseases. However, data are lacking to affirm the necessity of testing these patients for human T-lymphotropic ...
Fabíola Suris da Silveira   +1 more
doaj   +2 more sources

COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier

open access: yesClinical Case Reports, 2022
This is the first report of COVID‐19 in a human T‐cell lymphotropic virus type‐1 (HTLV‐1) carrier. HTLV‐1 infection can cause immune dysfunction even in asymptomatic carriers.
Takatoshi Enomoto   +17 more
doaj   +1 more source

HTLV-1 and Co-infections

open access: yesFrontiers in Medicine, 2022
Human T lymphotropic virus type 1 (HTLV-1) is a retrovirus that causes lifelong T-cell infection in humans, impacting the host immune response. This virus causes a range of clinical manifestations, from inflammatory conditions, including neuronal damage (
Carolina Rosadas   +2 more
doaj   +1 more source

Human T lymphotropic virus type 1 uveitis after Graves' disease. [PDF]

open access: bronzeBritish Journal of Ophthalmology, 1994
A distinct clinical entity of uveitis associated with human T lymphotropic virus type 1 (HTLV-I) has been reported previously. During the period between January 1989 and April 1992, 93 patients were observed with HTLV-I uveitis and a significant correlation was found between Graves' disease and HTLV-I uveitis.
Kazunari Yamaguchi   +9 more
openalex   +4 more sources

Acute Human T-Lymphotropic Virus Type 1–Associated Myelopathy [PDF]

open access: yesArchives of Neurology, 2003
Recently, acute human T-lymphotropic virus type 1-associated myelopathy (HAM) was reported clinically without pathologic information. We report an autopsy case of acute HAM.To report the case of a 52-year-old man with acute-onset gait disturbance followed by rapidly progressive paraplegia, who died 9 months later.The postmortem study showed swelling of
Naoki, Kasahata   +4 more
openaire   +2 more sources

Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1)

open access: greenRevista da Sociedade Brasileira de Medicina Tropical, 2003
José Roberto Lambertucci   +2 more
doaj   +2 more sources

Probable HTLV-I/II Tropical Spastic Paraparesis Patient from Ethiopia: A Case Report [PDF]

open access: yes, 2022
BACKGROUND: Available data on the burden of Human T-cell lymphotropic virus type I/II infection for eastern Africa, limited to Ethiopia, Mozambique, and Rwanda, show prevalence lower than elsewhere in Africa (0% - 1.8%).
Dereje Melka, Mehila Zebenigus
core   +2 more sources

Human T Lymphotropic Virus Type 1 Infection Influences Hepatitis C Virus Clearance [PDF]

open access: yesThe Journal of Infectious Diseases, 2001
To explore the effect of human T lymphotropic virus type 1 (HTLV-1) infection on hepatitis C virus (HCV) infection, a survey for these viral infections was conducted that involved 2280 residents in an area in which HTLV-1 and HCV are endemic. The response of patients with HCV and HTLV-1 to interferon (IFN)-alpha treatment was also assessed. Antibody to
Y, Kishihara   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy